300760.SZ
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 175.36
−1.37%Oct 29, 2026, 11:05 UTC
Mindray Medical reported third-quarter revenue of 9.35 billion yuan, up 2.85% year over year, and net profit attributable to shareholders of 2.387 billion yuan, down 4.55%; for the first three quarters, revenue was 27.097 billion yuan, up 4.89%, and net profit was 7.184 billion yuan, down 5.10%.
Source:Oct 12, 2026, 08:17 UTC
Mindray Medical's controlling shareholder, Magnifice HK Ltd., pledged 6.5 million company shares to CMB Wing Lung Bank Ltd. and Nanyang Commercial Bank Ltd..
Source:Aug 29, 2026, 11:56 UTC
Mindray Medical International disclosed its 2026 semi-annual report on August 28, 2026, reporting revenue of 17.747 billion yuan, up 6.00% year-on-year, and net profit attributable to shareholders of 4.797 billion yuan, down 5.37% year-on-year.
Source:Aug 28, 2026, 10:26 UTC
Mindray Medical announced a cash dividend of 13.3 yuan per 10 shares (tax included) based on its total share capital of 1.212 billion shares, with no bonus shares or capital reserve conversion.
Aug 10, 2026, 10:53 UTC
Mindray Medical completed the cancellation of 641,963 treasury shares on August 7, 2026, reducing its total share capital from 1,212,441,394 shares to 1,211,799,431 shares.
Source:Jul 30, 2026, 03:41 UTC
Mindray Medical established a wholly-owned medical technology subsidiary in Zhengzhou with a registered capital of 5 million yuan.
Source: